Walleye Trading’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,259
| Closed | -$70.9K | – | 4435 |
|
|
2026
Q1 | $70.9K | Sell |
3,259
-12,197
| -79% | -$236K | ﹤0.01% | 3582 |
|
|
2025
Q4 | $333K | Buy |
15,456
+3,228
| +26% | +$68K | ﹤0.01% | 3083 |
|
|
2025
Q3 | $236K | Buy |
12,228
+8,569
| +234% | +$153K | ﹤0.01% | 3255 |
|
|
2025
Q2 | $62.6K | Buy |
+3,659
| New | +$156K | ﹤0.01% | 3766 |
|
|
2025
Q1 | – | Sell |
-622
| Closed | -$75.6K | – | 4682 |
|
|
2024
Q4 | $75.6K | Hold |
622
| – | – | ﹤0.01% | 3668 |
|
|
2024
Q3 | $77.7K | Sell |
622
-17,426
| -97% | -$2.41M | ﹤0.01% | 3414 |
|
|
2024
Q2 | $2.85M | Buy |
18,048
+8,030
| +80% | +$1.03M | 0.01% | 1385 |
|
|
2024
Q1 | $1.3M | Sell |
10,018
-29,355
| -75% | -$3.6M | ﹤0.01% | 2041 |
|
|
2023
Q4 | $3.8M | Buy |
39,373
+9,551
| +32% | +$916K | 0.01% | 1424 |
|
|
2023
Q3 | $3.62M | Buy |
+29,822
| New | +$3.37M | 0.01% | 1343 |
|
|
2023
Q2 | – | Sell |
-12,569
| Closed | -$1.62M | – | 5178 |
|
|
2023
Q1 | $1.73M | Buy |
+12,569
| New | +$1.63M | ﹤0.01% | 1788 |
|
|
2022
Q4 | – | Sell |
-30,000
| Closed | -$3.48M | – | 5397 |
|
|
2022
Q3 | $3.32M | Buy |
+30,000
| New | +$3.02M | 0.01% | 1319 |
|
|
2022
Q1 | – | Sell |
-968
| Closed | -$87K | – | 5892 |
|
|
2021
Q4 | $87K | Buy |
+968
| New | +$82.8K | ﹤0.01% | 4451 |
|
|
2021
Q3 | – | Sell |
-1,427
| Closed | -$110K | – | 5688 |
|
|
2021
Q2 | $111K | Sell |
1,427
-1,699
| -54% | -$129K | ﹤0.01% | 4337 |
|
|
2021
Q1 | $233K | Buy |
+3,126
| New | +$288K | ﹤0.01% | 3484 |
|
|
2020
Q2 | – | Sell |
-18,721
| Closed | -$2.55M | – | 4585 |
|
|
2020
Q1 | $1.83M | Buy |
+18,721
| New | +$2.14M | 0.01% | 892 |
|
|
2019
Q3 | – | Sell |
-16,500
| Closed | -$1.95M | – | 4416 |
|
|
2019
Q2 | $2.51M | Buy |
16,500
+14,301
| +650% | +$1.74M | 0.02% | 883 |
|
|
2019
Q1 | $262K | Buy |
2,199
+1,611
| +274% | +$207K | ﹤0.01% | 2824 |
|
|
2018
Q4 | $64K | Sell |
588
-557
| -49% | -$69.7K | ﹤0.01% | 4058 |
|
|
2018
Q3 | $185K | Sell |
1,145
-6,715
| -85% | -$918K | ﹤0.01% | 3822 |
|
|
2018
Q2 | $1.04M | Buy |
+7,860
| New | +$741K | 0.01% | 2061 |
|
|
2016
Q3 | – | Sell |
-2,300
| Closed | -$69.5K | – | 5383 |
|
|
2016
Q2 | $44K | Buy |
+2,300
| New | +$42.6K | ﹤0.01% | 4056 |
|
Other funds holding SRPT
EAM
Walleye Trading's SRPT Position: Q2 2026 in Review
Walleye Trading sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 3,259 shares — an estimated $70.9K sold.
Walleye Trading first reported a position in SRPT in Q2 2016 and held it in 22 quarters. The position peaked at $3.8M in Q4 2023. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.
- Walleye Trading reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
- Walleye Trading sold 3,259 Sarepta Therapeutics shares in Q2 2026, an estimated $70.9K.
- Walleye Trading first reported a position in Sarepta Therapeutics in Q2 2016 and held it in 22 quarters.
- Walleye Trading's Sarepta Therapeutics position peaked at $3.8M in Q4 2023.
- 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.
Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.